Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Nyiregyhaza

163 clinical trials in Nyiregyhaza, Hungary across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Nyiregyhaza at a glance
163
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

163 trials in Nyiregyhaza

Open in trial search
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Enfortumab Vedotin
  • Sponsor:Eli Lilly & Co.
Countries:HungaryHungary
  • Participants:18–64 years
  • Substances:Bevacizumab
  • Sponsor:Amgen Inc.
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:XMAB942
  • Sponsor:Xencor Inc.
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Sponsor:Newron Pharmaceuticals S.p.A.
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Tozorakimab
  • Sponsor:AstraZeneca AB

Other cities in Hungary

The busiest research cities in the country

All 70 cities in Hungary

Clinical research in Nyiregyhaza

What the registry says about research in the country

01 Oncology Research

Innovative trials focusing on breast cancer treatments, including studies for triple-negative and HR-positive/HER2-negative variants. Research extends to bladder cancer and lymphoma treatments.

  • Advanced metastatic breast cancer therapies
  • Large B-cell lymphoma treatments
  • Bladder cancer immunotherapy combinations

Several studies are evaluating novel drug combinations and comparing their efficacy to standard treatments.

02 Cardiovascular & Metabolic Diseases

Comprehensive research into heart failure prevention and treatment of cardiovascular disease. Studies include innovative approaches for managing chronic conditions.

  • Heart failure prevention strategies
  • Cardiovascular risk reduction
  • Chronic kidney disease management

Trials are investigating new therapeutic combinations to improve patient outcomes in cardiovascular conditions.

03 Respiratory & Inflammatory Conditions

Studies addressing chronic rhinosinusitis and respiratory infections, with particular focus on nasal polyps treatment and viral lung infections.

  • Nasal polyps treatment innovations
  • Respiratory syncytial virus prevention
  • Asthma management strategies

Research includes both preventive measures and therapeutic interventions for respiratory conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).